Duke succeeds in delivering the finest health care because our dedicated clinical teams are guided by extraordinary leaders. Directorships enable these luminaries to advance health through their clinical work with patients, their contributions to research and education, and their ability to mentor and inspire the people around them.
Excellence in clinical care leadership has never been more important than it is today. Clinicians have access to vast stores of information and new technology that are changing the face of patient care. Exceptional leaders are needed to fully realize the benefit of these advances.
By recruiting and retaining the best leaders in medicine and nursing, Duke will revolutionize patient care, improve outcomes, and help every patient live their best life today and tomorrow.
Establishing an Endowed Directorship
Supporters inspired by our shared mission to provide world-class patient care can fund directorships at several levels:
- Clinical Service Directorships support extraordinary leaders who ensure Duke’s dedicated clinical care teams deliver the highest-quality care.
- Medical Residency or Fellowship Program Directorships provide gifted educators and mentors with the resources they need to train future generations of world-class faculty and clinicians.
- Clinical Nursing Directorships recognize exceptional nurse leaders, ensuring they have the resources and support needed to innovate, lead, and achieve the best possible outcomes for our patients.
Endowed positions attract and retain researchers and clinicians at all career levels. They are among the most lasting and meaningful investments donors can make at Duke, as they pass from one exceptional recipient to the next overtime, yielding benefits for generations to come. We invite you to join us as we bring new discoveries, new therapies, and new innovations to the world.
Learn more or contact us to learn more about creating your own directorship at Duke University Health System.
Meet the holders of DUHS Endowed Directorships
The Joseph O. Moore, MD Director
Given by: Anonymous Donors
An anonymous couple chose to name this directorship in honor of Dr. Joseph O. Moore, a longtime Duke cancer physician and researcher who specializes in blood cancers, including leukemia and lymphoma. Across a career spanning more than 40 years, he earned a reputation for pairing exceptional medical expertise with a deeply personal, compassionate approach—guided by a belief in caring for the whole patient, not just the disease. His work in clinical trials helped advance treatments that have turned some once fatal leukemias into manageable conditions, allowing patients to live longer, fuller lives with fewer side effects. Dr. Moore retired from clinical practice in 2019.
The Moore Directorship supports a clinician of distinction in the field of oncology.
Current holder: Diane L. Reidy-Lagunes, MD
Dr Reidy-Lagunes is chief of the Division of Medial Oncology and Vice President for Oncology Services for Duke University Healthy System. She comes to Duke from Memorial Sloan Kettering Cancer Center (MSKCC). Her previous roles included president of MSKCC's Medical Staff, associate deputy physician-in-chief for clinical operations in the Regional Care Network, physician liaison for the Patient and Family Advisory Council on Quality, clinical director for the GI oncology service, and co-director of the Medical Oncology/Hematology Fellowship Program in the Department of Medicine. Additionally, she was the creator and host of an award-winning monthly podcast called "Cancer Straight Talk" which connects patients to cancer experts with the goal of having evidenced-based conversations on a variety of topics in cancer care.
As a researcher, Dr. Reidy-Lagunes focuses on developing methods to integrate molecular-based therapies into the treatment of neuroendocrine and adrenal tumors. She is a member of the National Cancer Institute Task Force on Neuroendocrine Tumors and the National Cancer Care Network Guidelines, and she is a former board member of the North American Neuroendocrine Tumor Society. She has received numerous awards and honors, including the Paul Sherlock Resident Housestaff Teaching Award and recognition as one of Castle Connolly's Top Doctors 2017-2025.
Kent and Siri Rawson Director
Given by: E. KENT RAWSON AND SIRI RAWSON
The late Kent Rawson and his wife, Siri, are recognized for their philanthropy, which grew from his success in business and their shared commitment to supporting their community. Mr. Rawson was an engineer and entrepreneur who founded Environmental Technologies, Inc. in the Tampa Bay area and led the company for nearly three decades, building a reputation as a leader in the commercial HVAC industry. Following his passing in 2013, Siri Rawson has continued their shared philanthropic vision as a director of the Rawson Charitable Foundation, which supports a range of charitable causes. Together, the Rawsons are recognized for translating business success into sustained charitable engagement focused on improving lives and strengthening communities.
The Rawson Directorship supports a clinical physician who is a scholar of excellence in advanced coronary artery disease.
Current holder: William Schuyler Jones, MD
I am an interventional cardiologist with a specific focus on the diagnosis and treatment of patients with cardiovascular disease. As a clinician, I see patients in the office and do coronary and peripheral vascular procedures (angiography and interventions) in the Duke Cardiac Catheterization Laboratory. I have served as the Medical Director of the cath lab at Duke since 2016. Alongside my partners in the cath lab, we collaborate with our cardiothoracic surgeons to hold Heart Team meetings each week, and we frequently are asked to address complex cardiovascular issues as a multidisciplinary team.
I also have a broad background in cardiovascular site-based research, multicenter clinical trials, clinical event classification, and observational analyses. I have helped to lead clinical trial efforts at the Duke Clinical Research Institute (DCRI) by designing and conducting studies evaluating new and existing treatments for patients with coronary artery disease and peripheral artery disease. My specific research interests include examining access to care and disparities in care for patients with peripheral artery disease and the design and conduct of pragmatic clinical trials in cardiovascular disease.
.png)